Subscribe Now

Sign up. Hear first.

Gilead and Galapagos have joined forces and pooled expertise. Now, in partnership with experts like you, we are taking on the challenges of IBD to help patients living with the disease. To follow our progress and receive the latest content on IBD, enter your details below.

*Indicates required field

By signing up to receive updates I consent to be contacted by Gilead Sciences Europe Ltd and by Galapagos NV by electronic means (such as email or SMS) with information about Gilead’s and Galapagos’ products and services and/or pharmaceutical promotional materials. By law, Gilead and Galapagos are required to obtain your consent in order to send you these electronic communications. You have the right to optout of receiving such electronic communications, at any time, by contacting Gilead and/or Galapagos or by clicking the unsubscribe link contained in each mail sent by us.

Gilead and Galapagos may share your personal data with other Gilead and Galapagos affiliates and/or third party vendors who provide services to Gilead or Galapagos for the purposes of providing you with these updates, but Gilead and/or Galapagos shall remain responsible for the confidentiality and security of your personal data at all times. We will not sell or rent your personally identifiable information. For further information about how Gilead and Galapagos handle your personal data and your rights please read our privacy statements: https://www.gilead.com/privacy-statements and https://www.glpg.com/privacy-notice.